NASDAQ

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares (QNTM)

524 Thanks from members

Quantum BioPharma (QNTM) faces a volatile market environment characterized by recent FDA clearance for its Phase 2 Lucid-MS trial, balanced against strict regulatory uncertainty, ongoing cash burn, and mixed quantitative sentiment signals.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →